CO2023016204A2 - Inhibidores de nlrp3 - Google Patents
Inhibidores de nlrp3Info
- Publication number
- CO2023016204A2 CO2023016204A2 CONC2023/0016204A CO2023016204A CO2023016204A2 CO 2023016204 A2 CO2023016204 A2 CO 2023016204A2 CO 2023016204 A CO2023016204 A CO 2023016204A CO 2023016204 A2 CO2023016204 A2 CO 2023016204A2
- Authority
- CO
- Colombia
- Prior art keywords
- nlrp3 inhibitors
- compounds
- nlrp3
- inhibitors
- methods
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general Ib, en donde R1, R2, R3, R4, R5 y Z son como se describen en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21173452 | 2021-05-12 | ||
EP21209447 | 2021-11-22 | ||
EP21215859 | 2021-12-20 | ||
PCT/EP2022/062525 WO2022238347A1 (en) | 2021-05-12 | 2022-05-10 | Nlrp3 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2023016204A2 true CO2023016204A2 (es) | 2023-12-11 |
Family
ID=81941106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2023/0016204A CO2023016204A2 (es) | 2021-05-12 | 2023-11-29 | Inhibidores de nlrp3 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP4337652A1 (es) |
JP (1) | JP2024517917A (es) |
KR (1) | KR20240007152A (es) |
AR (1) | AR125818A1 (es) |
AU (1) | AU2022275300A1 (es) |
BR (1) | BR112023023527A2 (es) |
CA (1) | CA3214626A1 (es) |
CO (1) | CO2023016204A2 (es) |
CR (1) | CR20230529A (es) |
IL (1) | IL307188A (es) |
PE (1) | PE20240126A1 (es) |
TW (1) | TW202311245A (es) |
WO (1) | WO2022238347A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023131277A1 (zh) * | 2022-01-07 | 2023-07-13 | 药捷安康(南京)科技股份有限公司 | Nlrp3炎症小体抑制剂及其应用 |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
WO2024094185A1 (zh) * | 2022-11-04 | 2024-05-10 | 药捷安康(南京)科技股份有限公司 | Nlrp3炎症小体抑制剂及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR119731A1 (es) | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
-
2022
- 2022-05-10 IL IL307188A patent/IL307188A/en unknown
- 2022-05-10 KR KR1020237038678A patent/KR20240007152A/ko unknown
- 2022-05-10 AR ARP220101225A patent/AR125818A1/es unknown
- 2022-05-10 EP EP22728228.2A patent/EP4337652A1/en active Pending
- 2022-05-10 PE PE2023002971A patent/PE20240126A1/es unknown
- 2022-05-10 WO PCT/EP2022/062525 patent/WO2022238347A1/en active Application Filing
- 2022-05-10 AU AU2022275300A patent/AU2022275300A1/en active Pending
- 2022-05-10 JP JP2023569634A patent/JP2024517917A/ja active Pending
- 2022-05-10 CA CA3214626A patent/CA3214626A1/en active Pending
- 2022-05-10 CR CR20230529A patent/CR20230529A/es unknown
- 2022-05-10 BR BR112023023527A patent/BR112023023527A2/pt unknown
- 2022-05-11 TW TW111117580A patent/TW202311245A/zh unknown
-
2023
- 2023-11-29 CO CONC2023/0016204A patent/CO2023016204A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112023023527A2 (pt) | 2024-01-30 |
AU2022275300A1 (en) | 2023-09-21 |
WO2022238347A1 (en) | 2022-11-17 |
AR125818A1 (es) | 2023-08-16 |
IL307188A (en) | 2023-11-01 |
EP4337652A1 (en) | 2024-03-20 |
CA3214626A1 (en) | 2022-11-17 |
JP2024517917A (ja) | 2024-04-23 |
KR20240007152A (ko) | 2024-01-16 |
TW202311245A (zh) | 2023-03-16 |
PE20240126A1 (es) | 2024-01-22 |
CR20230529A (es) | 2023-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
CO2023016204A2 (es) | Inhibidores de nlrp3 | |
CL2020003007A1 (es) | Lactamas biciclicas y metodos de uso de las mismas (divisional solicitud no. 3486-2017) | |
BR112021024108A2 (pt) | Inibidores de tead e usos dos mesmos | |
CO2021002382A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa | |
CO2023004195A2 (es) | Compuestos heterocíclicos | |
CO2020012824A2 (es) | Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma | |
CL2020001871A1 (es) | Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco. | |
CO2019009373A2 (es) | Compuestos heterocíclicos útiles como inhibidores duales de atx/ca. | |
CL2021000361A1 (es) | Nuevos compuestos heterocíclicos como inhibidores de monoacilglicerol lipasa | |
UY39526A (es) | Inhibidores de kras g12d | |
CO2022002000A2 (es) | Nuevos inhibidores heterocíclicos de monoacilglicerol lipasa (magl) | |
CL2023003154A1 (es) | Compuestos heterocíclicos | |
CO2022002336A2 (es) | Compuestos heterocíclicos | |
BR112014030473A2 (pt) | novo diazaespirocicloalcano e azaespirocicloalcano | |
CO6300939A2 (es) | Compuestos novedosos que son inhibidores de erk referencia a una solicitud relacionada | |
CL2022000019A1 (es) | Nuevos compuestos heterocíclicos | |
CO2019002692A2 (es) | Nuevos derivados de isoxazolil éter como pam de gaba a alfa5. | |
CO2023016212A2 (es) | Derivados de triazina y su uso en el tratamiento del cáncer | |
CL2022000556A1 (es) | Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de magl | |
CL2022000551A1 (es) | Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de magl | |
CL2023002429A1 (es) | Derivados novedosos de pirimidin-2-il sulfonamida | |
CL2022002661A1 (es) | Derivados de benzodiazepinas como pam de gaba a gamma1 | |
CL2022000802A1 (es) | Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3 | |
CO2024004552A2 (es) | Compuestos heteroarilo bicíclicos fusionados útiles como inhibidores de nlrp3 |